Discover

SCPH
scPharmaceuticals Inc.
5.67
undefined x undefined
undefined x undefined
bid
ask
+
0.00
0.00%
04:00 PM
Ytd60.17%
1y32.48%
5.67
day range
5.67
52 week range
Open5.67Prev Close5.67Low5.67High5.67Mkt Cap171.14M
Vol10.90MAvg Vol0.00EPSN/AP/EN/AForward P/E-4.68
Beta0.31Short Ratio11.41Inst. Own81.64%DividendN/ADiv YieldN/A
Ex Div DateN/AEarningN/A50-d AvgN/A200-d AvgN/A1yr Est17.50

SCPH News

SCPHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of scPharmaceuticals Inc. - SCPH
businesswire.com
SCPHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC

NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti,

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VTLE and SCPH on Behalf of Shareholders
globenewswire.com
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VTLE and SCPH on Behalf of Shareholders

NEW YORK, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is invest

SCPH Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of scPharmaceuticals to MannKind
globenewswire.com
SCPH Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of scPharmaceuticals t

MONSEY, N.Y., Aug. 25, 2025 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating

MannKind, Backed By Blackstone, Expands Cardiorenal Focus With $360 Million Deal
benzinga.com
MannKind, Backed By Blackstone, Expands Cardiorenal Focus With $360 Million Deal

MannKind will acquire scPharmaceuticals in a $360 million deal, adding Furoscix and expanding into c

SCPH Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of scPharmaceuticals Inc. Is Fair to Shareholders
businesswire.com
SCPH Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of scPharmaceuticals Inc. Is Fa

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether t

Shareholder Alert: The Ademi Firm Investigates Whether scPharmaceuticals Inc. Is Obtaining a Fair Price for Its Public Shareholders
businesswire.com
Shareholder Alert: The Ademi Firm Investigates Whether scPharmaceuticals Inc. Is Obtaining a Fair Pr

MILWAUKEE--(BUSINESS WIRE)--The Ademi Firm is investigating scPharmaceuticals (NASDAQ: SCPH) for pos

MannKind to Acquire scPharmaceuticals, Accelerating Revenue Growth and Emerging as a Patient-Centric Leader in Cardiometabolic and Lung Diseases
globenewswire.com
MannKind to Acquire scPharmaceuticals, Accelerating Revenue Growth and Emerging as a Patient-Centric

DANBURY, Conn. and BURLINGTON, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq

scPharmaceuticals Receives Notice of Allowances of Multiple US Patent Applications Covering SCP-111
globenewswire.com
scPharmaceuticals Receives Notice of Allowances of Multiple US Patent Applications Covering SCP-111

BURLINGTON, Mass., Aug. 14, 2025 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH) (the “Com

scPharmaceuticals Inc. (SCPH) Q2 2025 Earnings Call Transcript
seekingalpha.com
scPharmaceuticals Inc. (SCPH) Q2 2025 Earnings Call Transcript

scPharmaceuticals Inc. (NASDAQ:SCPH ) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Com

scPharmaceuticals, Inc. (SCPH) Reports Q2 Loss, Lags Revenue Estimates
zacks.com
scPharmaceuticals, Inc. (SCPH) Reports Q2 Loss, Lags Revenue Estimates

scPharmaceuticals, Inc. (SCPH) came out with a quarterly loss of $0.34 per share versus the Zacks Co

scPharmaceuticals Inc. Reports Second Quarter 2025 Financial Results and Provides Business Update
globenewswire.com
scPharmaceuticals Inc. Reports Second Quarter 2025 Financial Results and Provides Business Update

Generated net FUROSCIX ® revenue of $16 million in the second quarter of 2025; up 99% over Q2 2024

benzinga.com
Earnings Scheduled For August 7, 2025

scPharmaceuticals to Announce Second Quarter 2025 Financial Results After the Market Close on August 7, 2025
globenewswire.com
scPharmaceuticals to Announce Second Quarter 2025 Financial Results After the Market Close on August

BURLINGTON, Mass., July 31, 2025 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharma

scPharmaceuticals (SCPH) Soars 8.8%: Is Further Upside Left in the Stock?
zacks.com
scPharmaceuticals (SCPH) Soars 8.8%: Is Further Upside Left in the Stock?

scPharmaceuticals (SCPH) witnessed a jump in share price last session on above-average trading volum

scPharmaceuticals: Furoscix Sales To Accelerate Throughout 2025
seekingalpha.com
scPharmaceuticals: Furoscix Sales To Accelerate Throughout 2025

Shares of scPharmaceuticals have lost 37% over the past 3 years and are down 11% in 2025. Furoscix's

scPharmaceuticals Inc. (SCPH) Q1 2025 Earnings Call Transcript
seekingalpha.com
scPharmaceuticals Inc. (SCPH) Q1 2025 Earnings Call Transcript

scPharmaceuticals Inc. (NASDAQ:SCPH ) Q1 2025 Earnings Conference Call May 14, 2025 4:30 PM ET Compa

ScPharmaceuticals, Inc. (SCPH) Reports Q1 Loss, Misses Revenue Estimates
zacks.com
ScPharmaceuticals, Inc. (SCPH) Reports Q1 Loss, Misses Revenue Estimates

ScPharmaceuticals, Inc. (SCPH) came out with a quarterly loss of $0.34 per share versus the Zacks Co

scPharmaceuticals Inc. Reports First Quarter 2025 Financial Results and Provides Business Update
globenewswire.com
scPharmaceuticals Inc. Reports First Quarter 2025 Financial Results and Provides Business Update

Generated net FUROSCIX ® revenue of $11.8 million in the first quarter of 2025 Formally launched FUR

benzinga.com
Earnings Scheduled For May 14, 2025

scPharmaceuticals to Announce First Quarter 2025 Financial Results After the Market Close on May 14, 2025
globenewswire.com
scPharmaceuticals to Announce First Quarter 2025 Financial Results After the Market Close on May 14,

Management to host conference call and webcast, after-market on May 14, 2025, at 4:30 p.m. ET Manage

scPharmaceuticals Announces Participation in Three Upcoming Investor Conferences
globenewswire.com
scPharmaceuticals Announces Participation in Three Upcoming Investor Conferences

BURLINGTON, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH) (the “Comp

scPharmaceuticals Inc. (SCPH) Q4 2024 Earnings Call Transcript
seekingalpha.com
scPharmaceuticals Inc. (SCPH) Q4 2024 Earnings Call Transcript

scPharmaceuticals Inc. (NASDAQ:SCPH ) Q4 2024 Results Conference Call March 19, 2025 4:30 PM ET Comp

benzinga.com
Earnings Scheduled For March 19, 2025

benzinga.com
Earnings Scheduled For November 13, 2024

benzinga.com
Earnings Scheduled For March 13, 2024

Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarte

benzinga.com
Earnings Scheduled For November 8, 2023

Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its

benzinga.com
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2023

benzinga.com
Earnings Scheduled For August 10, 2023

Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterl

benzinga.com
Earnings Scheduled For May 10, 2023

Companies Reporting Before The Bell • Nomad Foods (NYSE:NOMD) is projected to report quarterly earn

benzinga.com
Earnings Scheduled For March 22, 2023

Companies Reporting Before The Bell • Boyd Gaming (NYSE:BYD) is estimated to report quarterly earni

benzinga.com
Earnings Scheduled For November 9, 2022

Companies Reporting Before The Bell • GCM Grosvenor (NASDAQ:GCMG) is likely to report quarterly ear

benzinga.com
Why Laser Photonics Shares Jumped By Around 44%; Here Are 72 Biggest Movers From Yesterday

Gainers FedNat Holding Company (NASDAQ: FNHC) shares climbed 107.7% to close at $0.3395 on Tuesda

benzinga.com
Why Myovant Sciences Is Trading Higher By Over 26%; Here Are 31 Stocks Moving Premarket

Gainers Wearable Devices Ltd. (NASDAQ: WLDS) rose 58% to $1.39 in pre-market trading after declin

benzinga.com
78 Biggest Movers From Yesterday

Gainers Obalon Therapeutics, Inc. (NASDAQ: OBLN) shares climbed 115% to close at $2.30 on Monday

benzinga.com
54 Stocks Moving In Monday's Mid-Day Session

Gainers Obalon Therapeutics, Inc. (NASDAQ: OBLN) shares jumped 115.9% to $2.31 after declining ar

benzinga.com
Stocks That Hit 52-Week Highs On Friday

Stocks That Hit 52-Week Highs On Friday

benzinga.com
95 Biggest Movers From Yesterday

95 Biggest Movers From Yesterday

benzinga.com
Stocks That Hit 52-Week Highs On Thursday

Stocks That Hit 52-Week Highs On Thursday

benzinga.com
Stocks That Hit 52-Week Highs On Tuesday

Stocks That Hit 52-Week Highs On Tuesday

benzinga.com
Stocks That Hit 52-Week Highs On Monday

Stocks That Hit 52-Week Highs On Monday

benzinga.com
40 Biggest Movers From Yesterday

40 Biggest Movers From Yesterday

benzinga.com
45 Stocks Moving In Wednesday's Mid-Day Session

45 Stocks Moving In Wednesday's Mid-Day Session

benzinga.com
55 Biggest Movers From Friday

55 Biggest Movers From Friday

benzinga.com
48 Biggest Movers From Yesterday

48 Biggest Movers From Yesterday

benzinga.com
Stocks Which Set New 52-Week Low Yesterday, August 15th

Stocks Which Set New 52-Week Low Yesterday, August 15th

benzinga.com
Stocks Which Set New 52-Week Low Yesterday, August 14th

Stocks Which Set New 52-Week Low Yesterday, August 14th

benzinga.com
Stocks Which Set New 52-Week Lows Friday

Stocks Which Set New 52-Week Lows Friday

benzinga.com
36 Biggest Movers From Friday

36 Biggest Movers From Friday